Mexiletine how supplied storage and handling: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Mexiletine}} {{CMG}}; {{AE}} {{SS}} ==How Supplied Storage And Handling== Mexiletine hydrochloride capsules USP, 150 mg are white granular powder in a hard gelat...")
 
(Redirected page to Mexiletine#How Supplied)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Mexiletine#How Supplied]]
{{Mexiletine}}
{{CMG}}; {{AE}} {{SS}}
 
==How Supplied Storage And Handling==
 
Mexiletine hydrochloride capsules USP, 150 mg are white granular powder in a hard gelatin capsule with an opaque tan cap and an opaque orange body, imprinted with "N" on one side and "739" and "150" on the other in black ink. They are supplied as follows: NDC 0093-8739-01 bottles of 100.
 
Mexiletine hydrochloride capsules USP, 200 mg are white granular powder in a hard gelatin capsule with an opaque orange cap and an opaque orange body, imprinted with "N" on one side and "740" and "200" on the other in black ink. They are supplied as follows: NDC 0093-8740-01 bottles of 100.
 
Mexiletine hydrochloride capsules USP, 250 mg are white granular powder in a hard gelatin capsule with an opaque green cap and an opaque orange body, imprinted with "N" on one side and "741" and "250" on the other in black ink. They are supplied as follows: NDC 0093-8741-01 bottles of 100.
 
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required)..<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=693da40b-26d4-40d6-87d1-158e256f40ab | publisher =  | date =  | accessdate = 3 March 2014 }}</ref>
==References==
{{Reflist}}
 
{{Antiarrhythmic agents}}
 
[[Category:Sodium channel blockers]]
[[Category:Phenol ethers]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 21:54, 21 July 2014